Creating a new type of HIV for studying AIDS
Engineering simian-compatible HIV-1
This study is looking at a specially modified version of the HIV virus to help researchers learn how it affects the immune system, which could lead to better treatments and vaccines for people living with HIV/AIDS.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of North Texas Hlth Sci Ctr NIH-funded |
| Lab location | 1 site (Fort Worth, United States) |
| Project ID | NIH-11009371 on NIH RePORTER |
What this research studies
This research focuses on engineering a modified version of the HIV virus that is compatible with simian models to better understand AIDS pathogenesis. By constructing a chimeric HIV-1 backbone with minimal SIV gene fragments, the study aims to investigate how this modified virus can activate resting T cells, which is crucial for understanding HIV replication and developing effective vaccines and therapies. Patients may benefit from insights gained through this research, which could lead to improved treatments for HIV/AIDS. The methodology involves using human peripheral blood mononuclear cells to test the activation of T cells by the engineered virus.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research would be individuals affected by HIV/AIDS or those at high risk of infection.
Not a fit: Patients who are not affected by HIV/AIDS or do not have risk factors for the virus may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to breakthroughs in understanding and treating HIV/AIDS.
How similar studies have performed: Previous research with similar approaches has shown promise, particularly in the use of chimeric viruses for studying HIV dynamics.
Where this research is happening
Fort Worth, United States
- University of North Texas Hlth Sci Ctr — Fort Worth, United States (Active)
Researchers
- Principal investigator: Park, in-Woo — University of North Texas Hlth Sci Ctr
- Study coordinator: Park, in-Woo
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.